DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Shibayama Y, Nakano K, Maeda H. et al.
Multidrug resistance protein 2 implicates anticancer drug-resistance to sorafenib.
Biol Pharm Bull 2011;
34 (03) 433-435
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.